Quantcast

Latest Ethyl eicosapentaenoic acid Stories

2014-08-19 12:28:48

WOODBRIDGE, ON, Aug. 19, 2014 /PRNewswire/ - Pivotal Therapeutics Inc. (OTCQX:PVTTF; CSE:PVO), ("Pivotal" or the "Company"), a specialty pharmaceutical company with a focus on Omega-3 therapies for cardiovascular disease ("CVD") and overall health, announced today that an article entitled, "Redox-sensitive induction of Src/PI3-kinase/Akt and MAPKs pathways activate eNOS in response to EPA:DHA 6:1," authored by Faraj Zgheel, Mahmoud Alhosin, Sherzad Rashid, Mélanie Burban, Cyril...

2014-08-06 12:29:21

WOODBRIDGE, ON, August 6, 2014 /PRNewswire/ - Pivotal Therapeutics Inc. (OTCQX:PVTTF; CSE:PVO), ("Pivotal" or the "Company"), a specialty pharmaceutical company with a focus on Omega-3 therapies for cardiovascular disease (CVD) and overall health, announced today that it has entered into a Memorandum of Understanding to create a Joint Venture Distribution Agreement with ACGT Corporation ("ACGT") and associates. A leader in Canada's DNA services industry with extensive ties to...

2014-07-13 23:03:12

Celebrity fitness trainer and former World Super Middleweight Champion, Danny Musico, has formed a promotional partnership with Aqua Health Labs for their flagship product, PhytOriginal, a revolutionary plant-based Omega-3 EPA supplement. The collaboration was recently announced live on ESPN Radio. Beverly Hills, California (PRWEB) July 13, 2014 Celebrity fitness trainer and former World Super Middleweight Champion, Danny Musico, has formed a promotional partnership with Aqua Health Labs...

2014-07-02 08:27:08

Researchers Confirm "Gut Instinct" of Anti-Inflammatory Effects of EPA and DHA STOCKHOLM, July 2, 2014 /PRNewswire-USNewswire/ -- New research shows that dietary fats impact gut bacteria - some for the better (omega-3 polyunsaturated fatty acids or PUFAs) and some for the worse (omega-6 PUFAs). The omega-3s EPA and DHA found in seafood and marine oils may reduce inflammation and increase beneficial microorganisms to protect against gastrointestinal (GI) diseases. These findings were...

2014-06-11 12:28:43

WOODBRIDGE, ON, June 11, 2014 /PRNewswire/ - Pivotal Therapeutics Inc. (OTCQX:PVTTF; CSE:PVO), ("Pivotal" or the "Company"), a specialty pharmaceutical company with a focus on Omega-3 therapies for cardiovascular disease (CVD) and overall health, announced today that it retained Kilmer Lucas Inc. to provide it with Canadian and U.S. investor relations and strategic advisory services. "As we begin to fully execute our growth strategy, we are confident that Kilmer Lucas is the right...

2014-05-30 16:25:12

WOODBRIDGE, ON, May 30, 2014 /PRNewswire/ - Pivotal Therapeutics Inc. (OTCQX:PVTTF) (CSE:PVO), ("Pivotal" or the "Company"), a specialty pharmaceutical company with a focus on Omega-3 therapies for cardiovascular disease (CVD) and overall health, announced its operational highlights and financial results for the three months ended March 31, 2014. All dollar amounts referenced herein are in Canadian dollars unless otherwise stated. Financial Results For the three months ended March 31, 2014,...

2014-05-14 20:23:53

WOODBRIDGE, ON, May 14, 2014 /PRNewswire/ - Pivotal Therapeutics Inc. (OTCQX:PVTTF)(CSE:PVO) ("Pivotal" or "the Company"), a specialty pharmaceutical company with a focus on Omega-3 therapies for cardiovascular disease and overall health, today announced changes to its Board designed to increase its independence and enhance Pivotal's corporate governance at this stage of the Company's development. Dr. Jackowski has stepped down as Chairman of Pivotal Therapeutics Inc. effective May...

2014-05-13 16:27:44

WOODBRIDGE, ON, May 13, 2014 /PRNewswire/ - Pivotal Therapeutics Inc. (OTCQX: PVTTF) (CSE: PVO), a specialty pharmaceutical company with a focus on Omega-3 therapies for cardiovascular disease (CVD) and overall health, announced that it has engaged Brandkarma LLC., an award winning, US-based, healthcare marketing and brand specialist with global expertise to support the Company's commercialization strategy for VASCAZEN(®). "VASCAZEN(®) represents a much-needed solution for...

2014-05-07 12:30:30

WOODBRIDGE, ON, May 7, 2014 /PRNewswire/ - Pivotal Therapeutics Inc. (OTCQX: PVTTF) (CSE: PVO), a specialty pharmaceutical company with a focus on Omega-3 therapies for cardiovascular disease (CVD) and overall health, announced today that the U.S. Patent and Trademark Office (USPTO) has issued Patent Number 8,715,648 titled "Formulations Comprising Omega-3 Fatty Acids and Anti-Obesity Agent for the Reduction of Body Weight in Cardiovascular Disease Patients (CVD) and Diabetics"....

2014-05-06 16:31:55

WOODBRIDGE, ON, May 6, 2014 /PRNewswire/ - Pivotal Therapeutics Inc. (OTCQX: PVTTF) (CSE: PVO), a specialty pharmaceutical company with a focus on Omega-3 therapies for cardiovascular disease (CVD) and overall health, is pleased to announce that it presented two posters at the American Heart Association's Arteriosclerosis, Thrombosis and Vascular Biology (ATVB) 2014 Scientific Sessions held in Toronto, Ontario, Canada, May 1-3, 2014. Both posters discussed Omega-3 deficiency (OM3D)...


Word of the Day
lunula
  • A small crescent-shaped structure or marking, especially the white area at the base of a fingernail that resembles a half-moon.
This word is a diminutive of the Latin 'luna,' moon.
Related